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Introduction
Because of their natural ability to secrete high amounts of 
extracellular proteins, filamentous fungi have been extensively 
exploited for the production of homologous and heterologous 
proteins. Although homologous protein production can reach 
the level of hundreds of grams per liter, the production levels of 
heterologous proteins can be several orders of magnitude lower.1,2 
In the search to further improve the properties of fungi as protein 
producers, many strategies have been employed and optimized, 
including signal sequence optimization, use of strong promoters, 
co-expression of chaperones and foldases, genetic modifications 
which improve secretion capabilities (such as the knockout of 
specific genes or random mutagenesis), reduction of proteolytic 
activity,3 optimization of fermentation conditions, among oth-
ers.4-10 Improvement of the secretion of extracellular enzymes by 
the application of random mutagenesis and screening has been 
successfully performed in various filamentous fungi.11,12 Many of 
the high-secreting mutants isolated are currently used for indus-
trial production of fungal enzymes and applied as expression 
hosts for recombinant gene products.13
It is a routine practice to develop mutants through random 
mutagenesis. Strain improvement by random mutagenesis is a suc-
cessful method, but it is mainly a trial-and-error process, involv-
ing laborious procedures. Moreover, in many cases improved 
To improve the general secretion ability of the biotechnologically relevant fungus Ashbya gossypii, random mutagenesis 
with ethyl methane sulfonate (eMS) was performed. The selection and screening strategy followed revealed mutants 
with improved secretion of heterologous Trichoderma reesei endoglucanase I (eGI), native α-amylase and/or native 
β-glucosidase. One mutant, S436, presented 1.4- to 2-fold increases in all extracellular enzymatic activities measured, 
when compared with the parent strain, pointing to a global improvement in protein secretion. Three other mutants 
exhibited 2- to 3-fold improvements in only one (S397, B390) or two (S466) of the measured activities.
a targeted genetic approach was also followed. Two homologs of the Saccharomyces cerevisiae GAS1, AgGAS1A (AGL351W) 
and AgGAS1B (AGL352W), were deleted from the A. gossypii genome. For both copies deletion, a new antibiotic marker 
cassette conferring resistance to phleomycin, BLe3, was constructed. GAS1 encodes an β-1,3-glucanosyltransglycosylase 
involved in cell wall assembly. higher permeability of the cell wall was expected to increase the protein secretion capac-
ity. however, total protein secreted to culture supernatants and secreted eGI activity did not increase in the Aggas1AΔ 
mutants. Deletion of the AgGAS1B copy affected cellular morphology and resulted in severe retardation of growth, simi-
larly to what has been reported for GAS1-defficient yeast. Thus, secretion could not be tested in these mutants.
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performance is a black box, and the underlying mechanism is not 
easily identified.14 The main effect of mutagenic agents (X-rays, 
UV-rays, nitrous acid, dimethyl sulphonate, ethyl methane sulfo-
nate (EMS) and acridine mustards) relies on creating a lesion or 
a modification in the base sequence of the DNA molecule. If this 
lesion is not repaired a mutation is caused.15 The nature of the muta-
genic agent is such that changes are not directed exclusively at the 
loci which will generate beneficial change, requiring the screening 
of large numbers of strains for the desired phenotypes. Different 
methods have been used to introduce random mutations in dif-
ferent microorganisms,16 including mutagenesis using nitrous acid, 
hydroxylamine, UV radiation, transposons and EMS.17 Mutagenic 
procedures can be optimized in terms of type of mutagen, dose 
and temperature. EMS is an alkylating agent that induces point 
mutations by A-T transition to G-C.18 This mutagenic agent has 
been used to increase glucose oxidase activity,19 phytase,20 pec-
tinase,21 catalase,19 lipase,22 laccase23 and citric acid production in 
Aspergillus niger,24,25 as well as to improve recombinant strains of 
Saccharomyces cerevisiae26 and Trichoderma viride,27 among others.
Secretion of a heterologous protein often represents a major 
bottleneck. Once a protein has been released out of the ER–
Golgi system, it has to cross the cell wall. Mutations in genes 
involved in the construction and in the maintenance of the cell 
wall, such as PMR1, SEC14, ERD1, MNN9 and MNN10, have in 
some cases been demonstrated to lead to supersecreting mutants 
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needle shape spores difficult to separate, treatment with EMS 
resulted in highly variable numbers of colonies per plate after 
treatment. Between 46–100% lethality was obtained when using 
5–20% (v/v) EMS during 1 and 2 h of incubation at room tem-
perature. One hundred per cent mortality was recorded after 
3 h of EMS treatment. Average killing rates of 50–90% were 
obtained after treatment with 5% (v/v) EMS for 90 min, which 
were considered to be suitable for mutant screening (data not 
shown).
Mutant screening and characterization of putative A. gos-
sypii mutants with improved secretion capacity. Primary selec-
tion of hyperproducing mutants was done based on the diameter 
of the clearing zone surrounding the colony on the screening 
media containing 0.1% (w/v) carboxymethylcellulose (CMC) 
and G418 (200 μgml−1). In addition to CMC, mutants were 
also screened on starch and tributyrin agar plates for α-amylase 
and lipase activity, respectively. Screening on medium contain-
ing CMC gave a fairly reliable indication of increased cellulolytic 
activity, whereas screening on starch and tributyrin plates was 
less conclusive (data not shown).
In the primary selection, approximately 1000 mutant colo-
nies showing larger clearing zones than the control strain were 
isolated from the screening plates. Of these, the 39 mutants that 
presented the biggest haloes in the CMC plates were selected 
and enzyme production was determined in submerged cultures 
(Fig. 1). Comparison of the EGI and β-glucosidase extracellular 
activities between the control strain and the 39 selected mutants 
was made at several times after inoculation, to take into account 
differences in the lag phase or specific growth rate on enzyme 
production and/or secretion. The EGI and β-glucosidase specific 
activities (per gram of dry cell weight) quantified from the cul-
ture supernatants increased along the culture time reaching their 
maximum levels at the stationary phase (data not shown). From 
these 39 mutants, the most promising 5 were selected for further 
analysis, which showed increase in both EGI and β-glucosidase 
activity (mutant S436), only in EGI activity (mutants B390 and 
S466) or only in β-glucosidase activity (mutants B206 and S397) 
(Fig. 1).
The EGI, α-amylase and β-glucosidase specific activities 
measured from the supernatants of the selected mutants at dif-
ferent cultivation times are depicted in Figure 2. There were no 
significant (p > 0.05) differences in the specific growth rate of 
the mutants when compared with the parent strain. The specific 
growth rate varied between 0.09–0.16 h−1 in AFM, which was 
in agreement with values reported for the recombinant A. gos-
sypii VTT D-101398.36 Three mutants presented enhanced EGI 
activity (p < 0.05), with mutant B390 showing nearly a 3-fold 
increase and mutants S436 and S466 a 2-fold increase compared 
with the parent in flask culture after 63 h of growth (Fig. 2A). 
At this point all cultures had reached the stationary phase (data 
not shown). In comparison to the control strain, mutant S466 
also presented increased α-amylase activity (p < 0.01) at the 
deceleration phase (after 30 h and 43 h of growth) and mutant 
S436 presented an increase in both α-amylase and β-glucosidase 
activities as well (Fig. 2B and C). The mutant with the highest 
β-glucosidase activity was mutant S397, which produced 2-fold 
in S. cerevisiae and other yeast.28 In addition, the deletion of the 
cell wall cross-linking enzyme glycophospholipid-anchored sur-
face Gas1p led to an almost 7-fold increase in the level of human 
insulin-like growth factor 1 (hIGF1) in S. cerevisiae.29 In Pichia 
pastoris, deletion of the GAS1 homolog resulted in a supersecret-
ing phenotype for the heterologous Rhizopus oryzae lipase, but 
had no effect on the secretion of recombinant human trypsinogen 
and albumin.30 More recently, deletion of the Zygosaccharomyces 
bailii GAS1 homolog almost doubled the amount of recombinant 
Candida rugosa lipase and Yarrowia lipolytica protease extracel-
lular enzymatic activity, but no relevant effect was observed on 
recombinant human IL-1b secretion.31
Ashbya gossypii is a filamentous hemiascomycete32,33 with a 
natural capacity to produce riboflavin (vitamin B2),34,35 which is 
used for the industrial production of this vitamin. The potential 
of A. gossypii as a host for recombinant protein production was pre-
viously evaluated by expressing cellobiohydrolase I (CBHI) and 
endoglucanase I (EGI) from Trichoderma reesei.36 However, the 
secretion levels obtained were very low, particularly in the case of 
CBHI.36 Here, we describe the improvement of the general secre-
tion capability of A. gossypii. Two approaches were used: random 
mutagenesis with EMS and direct mutagenesis by individual and 
multiple deletion from the genome of both copies of the GAS1 
gene, AgGAS1A (AGL351W ) and AgGAS1B (AGL352W ).
Results
EMS treatment parameters for mutagenesis of recombinant 
A. gossypii. Since A. gossypii spores cluster together in groups of 
Figure 1. eGI and β-glucosidase extracellular activity from 39 selected 
eMS treated A. gossypii mutants in small scale batch cultures. activities 
are expressed in percentage relative to those of the parent strain (U 
mg−1 protein for β-glucosidase and nkat mg−1 protein for eGI activ-
ity). The mutants B206, B390, S397, S436 and S466 identified in the 
figure were selected for further analysis. Mutants B390, S436 and S466 
showed improved eGI activity, whereas mutants B206, S397 and S436 
presented increased β-glucosidase activity.
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the heterokaryotic Aggas1AΔgas1BΔ double mutant also pre-
sented defects in sporulation. The mycelia of the Aggas1BΔ single 
mutant (Fig. 4G) presented granular cytoplasm and higher num-
ber of vacuoles than the parent strain (Fig. 4E). These were also 
bigger than the vacuoles observed in the mycelia from the par-
ent strain. Similarly, intracellular granules and altered vacuoles 
were also visible in the heterokaryotic Aggas1AΔgas1BΔ mutant 
(Fig. 4H), for which it was observed that a large fraction of cells 
underwent lysis even in the presence of an osmotic stabilizer. 
The extremely slow growth rates presented by the Aggas1BΔ 
null mutants imposed several experimental and processing con-
straints, hampering the evaluation of the effect of AgGAS1B dele-
tion on protein secretion.
The S. cerevisiae ADH1 terminator has been reported to dis-
play autonomous replicating sequence activity in A. gossypii.38 
In this study, the modification of the plasmid pMI519, which 
also included the removal of the S. cerevisiae ADH1 terminator 
sequence present, resulted in a 2-fold increase in the extracellu-
lar EGI activity, when compared with the strains expressing EGI 
from the original pMI519 plasmid (VTT D-101398 strain) (Fig. 
5). Therefore, the modified pMI519 plasmid was chosen to be 
introduced in the A. gossypi NQ89 strain to assess the effect of 
the AgGAS1A deletion in the production of T. reesei EGI. Two 
(p < 0.05) more compared with the non-mutagenized strain (Fig. 
2D). Thus, four mutants were isolated with improved extracel-
lular enzyme activity when compared with the parent strain.
Effect of AgGAS1 gene deletion on recombinant protein pro-
duction. For the inactivation of A. gossypii ATCC10895 AgGAS1A 
and AgGAS1B, the entire open reading frames AGL351W and 
AGL352W were replaced with the NATPS cassette flanked by 
66 bp and 67 bp upstream and downstream of AGL351W and 
AGL352W sequences, to enable homologous recombination and 
genomic insertion using a PCR strategy.37 As can be seen in 
Figure 3, AgGAS1A elimination was confirmed in three mutants. 
The expected size fragments (Fig. 3B) or no amplification (Fig. 
3C), were obtained. The mutants did not show any visible pheno-
type variation in comparison to the parent strain when grown on 
solid or in liquid AFM with glucose (Fig. 4A and B). However, 
microscopically it was observed that their mycelia presented more 
vacuoles than the parent strain mycelia (Fig. 4E and F).
Elimination of the AgGAS1B was also accomplished, as can 
be seen by the expected sizes of the products obtained from the 
verification PCR (Fig. 3D and E). The resulting mutants exhib-
ited an extremely slow growth rate on solid AFM medium (Fig. 
4C and D) and altered morphology (Fig. 4G and H), even on 
plates containing 1 M sorbitol as osmotic support. Moreover, 
Figure 2. extracellular enzyme activity from A. gossypii mutants obtained by random mutagenesis. eGI (A), α-amylase (B) and β-glucosidase (C and D) 
extracellular specific activities (per gram of dry weight) from A. gossypii eMS mutants and parent strain (control, VTT D-101398) in small scale batch cul-
tures. Values represent the standard error of the mean of two independent experiments with triplicates (n = 6). activities were analyzed with aNOVa 
using Graphpad from prism5 and significant differences (p < 0.05, p < 0.01 and p < 0.001) are indicated by asterisks (*, ** and ***, respectively).
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mutagenesis with the goal of increasing riboflavin production.39,40 
Although there are numerous studies on the application of EMS 
to induce mutagenesis in other microorganisms, this is the first 
time that A. gossypii secretion mutants have been produced by 
means of EMS mutagenesis.
EMS treatment was effective in generating A. gossypii mutants 
with improved extracellular enzymatic activities (Figs. 1 and 2), 
even though only 50–90% of killing was obtained after 90 min 
of incubation at room temperature with 5% (v/v) EMS. As no 
significant differences were observed between the growth of the 
parent and of the isolated mutant strains, the enhanced extra-
cellular enzyme production by the mutants was not due to an 
increase in growth, but to an improvement in protein production 
and/or secretion. Three mutants were isolated with enhanced 
EGI extracellular activity (Fig. 2A). One of these mutants (S436) 
Aggas1AΔ transformants expressing EGI and the negative control 
containing the empty vector were grown in 250 ml flasks in AFM 
supplemented with G418, in order to evaluate total extracellular 
EGI protein production. The amount of total protein secreted 
into the culture medium was very similar between the mutant 
(61–440 mg ml−1) and the parent VTT D-101398 strain (66–377 
mg ml−1). EGI activity, measured with the fluorogenic substrate 
MULac from the two Aggas1AΔ transformants and from the par-
ent EGI strain containing the modified vector did not differ sig-
nificantly (p > 0.05).
Discussion
Several mutants of A. gossypii have been generated using UV 
radiation and N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) 
Figure 3. pcR confirmation of GAS1 deletion in A. gossypii. (A) Schematic representation with the location of the primers used for verification of Ag-
GAS1A gene deletion and corresponding amplicon sizes. (B) pcR with primers V6FW_351 and V5RV_351 was made using as template: lanes 1, 2 and 3 
genomic DNa (gDNa) from homokaryotic transformants (predicted fragment size of 1618 bp); lane 5 parental gDNa (predicted fragment size of 1975 
bp). Lane 4 molecular marker (NZYTech) and lane 6 negative control. (C) pcR with primers V4FW_351 and V5RV_351 was made using as template: 
lanes 1, 2 and 3 gDNa from homokaryotic transformants (no amplification); and lane 5 parental gDNa (predicted fragment size of 1345 bp). Lane 4 
molecular marker (NZYTech) and lane 6 negative control. (D) Lane 1 molecular marker (NZYTech). Lanes 2, 4 and 6 parental gDNa respectively ampli-
fied with primers: V2FW_352 and V3RV_352 (predicted fragment size of 877 bp for the parent and no amplification in the deleted strain), V2FW_352 
and Ver352_RV (predicted fragment size of 1935 bp for the parent and 1692 bp when the deletion cassette has been integrated in the genome), and 
V2FW_352 and V1RV_NaTpS (predicted fragment size of 835 bp for the deleted strain and no amplification in the parental strain). Lanes 3, 5 and 7 
correspond to gDNa from a homokaryotic Agga1BΔ mutant amplified with the same sets of primers used with the parental strain. (E) Schematic repre-
sentation with the location of the primers used for verification of AgGAS1B deletion and corresponding amplicon sizes.
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bailii producing C. rugosa lipase Crl1p or Y. lipolytica protease 
Xpr2p.31 In A. fumigatus, an increase in glycoprotein secretion 
has also been reported for gel2Δ mutants.46
Since phylogenetically A. gossypii is closely related to S. cerevi-
siae33 and both show similar secretion characteristics,36 deletion of 
its GAS1 homologs might have been expected to result in similar 
improvements in secretion. However, the deletion of AgGAS1A 
from A. gossypii genome did not cause any effect on the capac-
ity of A. gossypii to secrete heterolougous EGI (Fig. 4) or native 
α-amylase (data not shown). Unlike in S. cerevisiae, there are two 
tandem copies of the GAS1 gene in the A. gossypii genome. Here 
we have only tested the effect of the AgGAS1A deletion on protein 
secretion, because both Aggas1BΔ and Aggas1AΔgas1BΔ mutants 
exhibited severe limitations in terms of growth. Therefore, 
there may still be sufficient protein in the wall of the Aggas1AΔ 
mutant to explain the lack of improved secretion. It is worth not-
ing that also in P. pastoris the disruption of GAS1 had no effect 
on the secretion of human trypsinogen or human serum albu-
min, although the amount of R. oryzae lipase released from the 
cells was doubled.31 Similarly, GAS1 deletion in Z. bailii did not 
increase human IL-1b secretion.32 Improvements in GAS1 dele-
tion strains have been protein dependent and EGI is not a read-
ily secreted protein. Altogether, this may have contributed to the 
lack of improvement.
The inactivation of the AgGAS1 homologs affected A. gossy-
pii morphology and growth rate, as already reported for other 
GAS1-defficient organisms. Similarly to what has been observed 
in yeast,29,30,32,47 A. gossypii Aggas1BΔ mutants exhibited severe 
growth retardation and abnormal cells with granular cytoplasm 
and big vacuoles. Moreover, the Aggas1AΔgas1BΔ double mutant 
presented sporulation deficiency and a high percentage of cellular 
lysis even when osmotic support was present. In A. fumigatus, 
abnormal conidiogenesis and slower growth were observed when 
GEL2, a ortholog of the GAS gene family, was deleted.46 These 
peculiar morphological alterations have been associated with 
altered structure and composition of the mutants cell wall.32,46,47
The major output of this study was one mutant with overall 
improved secretion capability obtained by random mutagenesis. 
Moreover, a new antibiotic marker cassette, BLE3, consisting 
of the bler gene from the bacterial transposon Tn5 flanked by 
the promoter and terminator sequences of the S. cerevisiae TEF2 
gene, has also been constructed for use in A. gossypii gene dele-
tions, allowing selection of phleomycin-resistant transformants. 
Targeted deletion of AgGAS1A had no significant effect on the 
overall A. gossypii secretion ability and the deletion of AgGAS1B 
led to defects in cellular growth, morphology and sporulation.
Materials and Methods
Strains. Recombinant A. gossypii VTT D-101398 expressing EGI 
from T. reesei, constructed previously,36 was used throughout 
this study. A. gossypii ATCC10895 (kindly provided by Prof. P. 
Philippsen from Basel) was used for gene deletion experiments.
Media. Ashbya Full Medium (AFM; 10 g l−1 peptone, 10 g l−1 
yeast extract, 1 g l−1 myo-inositol plus a carbon source) was used 
for growth of A. gossypii. Starch (10 g l−1), carboxymethylcellulose 
also presented increased α-amylase and β-glucosidase extracellu-
lar activities, as compared with the parent strain (Fig. 2B and C), 
indicating that the mutation(s) affected the secretory pathway in 
general. Other mutant (S466) showed a 3-fold increased extra-
cellular α-amylase activity as well, whereas mutant B390 only 
presented increased EGI activity. Additionally, one mutant was 
isolated which did not have improved EGI activity, but which 
produced more extracellular β-glucosidase (S397). In mutants 
B390, S397 and S466, as the mutation(s) only affected the pro-
duction and/or secretion of some enzymes, the activity increase 
observed corresponds to a specific event which may not be associ-
ated with an improvement on the secretory pathway per se, but 
be protein specific.
Mutant S436, with 1.4- to 2-fold improved secreted activity 
(Fig. 2), would be useful for further development of A. gossy-
pii protein production. 2-fold improvements in secreted hydro-
lytic activity are generally observed for other mutants obtained 
by random mutagenesis. For example, using different mutagens 
(ethidium bromide, NNMG and UV) to treat Trichoderma sp. 
and Aspergillus sp. spores, Chand et al.41 reported 1.9- to 2.9-fold 
increase in cellulase production. Dillon et al.42 reported 1.5-fold 
more cellulase productivity in Penicillium echinulatum by three 
repeated mutagenic treatment steps with UV radiation. T. viride 
TL-124 was subjected to successive mutagenic treatments, to 
obtain mutants with 2- to 2.6-fold increased cellulase production 
relative to the wild type strain.43 Aspergillus sp. has been improved 
for cellulase production by sequential treatments with γ radia-
tion, UV radiation and NNMG to obtain improved mutants 
which produced 2- to 3-fold improvements in cellulolytic activ-
ity.44 In this regard, the range of improvement obtained here 
is similar to what has been obtained in other microorganisms, 
although secretion is low compared with e.g., Trichoderma.
The low secretory ability of A. gossypii made screening for 
secretory mutants difficult. The difficulty of rapidly screening for 
cellulase hyperproducing mutants of Neurospora and Trichoderma 
has previously been noted.45 For A. gossypii, the haloes in agar 
plate assays were small and affected by the depth of agar and size 
of fungal colony. Germination time following mutagenesis was 
variable and thus colonies of different sizes needed to be com-
pared. It was also not practical to restrict colony expansion by 
inclusion of agents such as Tween 20 or Triton X100, which have 
been used with T. reesei,9 because they inhibited A. gossypii spores 
germination. Nonetheless, the screening method used did allow 
direct selection of hyperproducing mutants of the target protein 
from the colonies after mutagenesis, even though false positives 
were also isolated (Figs. 1 and 2).
Targeted genetic modification, by deletion of the A. gossypii 
GAS1 homologs, was less successful than random mutagenesis. 
GAS1 was chosen as a target for A. gossypii strain improvement 
because in yeast it encodes a cross-linking enzyme known to 
affect the structure and permeability of the cell wall. Cell wall 
defective strains deleted in the GAS1 gene of S. cerevisiae,29 P. 
pastoris30 and Z. bailii31 have been reported as super-secreting. 
Deletion of GAS1 in S. cerevisiae resulted in an almost 7-fold 
increase in the level of human hIGF1.29 Similarly, secreted enzy-
matic activity was almost doubled when GAS1 was deleted in Z. 
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Figure 4. colony and cellular morphology of A. gossypii parental and gas1 null mutant strains. From (A) to (D), A. gossypii parental and gas1 null mutant 
colonies are shown, which were inoculated in the middle of aFM plus glucose plates containing 1 M sorbitol and grown for one week at 30°c. panels 
(E) to (H) show microscope images of A. gossypii parental and gas1 null mutant mycelia and needle shaped spores harvested from the center of the 
colonies on the right. arrows indicate granules and enlarged vacuoles in mutant hyphae. In panel h, extensive cellular lysis is observed.
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min of incubation, 1 ml dinitrosalicylic acid color reagent was 
added. Samples were incubated in a boiling water bath for 5 min. 
After cooling to room temperature, 1 ml of water was added, 
samples were mixed and absorbance at 540 nm read vs. a blank. 
Maltose release was determined from a standard curve. One unit 
was defined as the amount of enzyme that released from soluble 
starch one micromole of reducing groups (calculated as maltose) 
per minute at 25°C and pH 6.9 under the specified conditions.
Lipase. Lipase was detected by growing the fungus on agar 
solidified trybutyrin AFM. Degradation of this compound gives 
rise to clear zones surrounding the lipolytic colonies in the other-
wise turbid culture medium.
Protein content. The protein concentration present in the 
supernatant was determined by the Bradford assay using bovine 
serum albumin (BSA; Sigma) as the standard.
GAS1-homolog genes deletion from the A. gossypii genome. 
In the A. gossypii genome, GAS1 is present as a tandem gene 
duplication, namely AgGAS1A (AGL351W ) and AgGAS1B 
(AGL352W ). In this study, A. gossypii gas1 null mutants were cre-
ated using a PCR-based, one-step gene targeting approach.37,50
For individual gene deletion, the disruption cassettes contain-
ing the NATPS marker, which confers resistance to nourseothri-
cin/clonNAT, were amplified by PCR from pUC19NATPS (D. 
Hoepfner, personal communication), using the primers 351FW 
and 351RV and 352FW and 352RV (Table 1). These primers 
were designed to have 66 bp and 67 bp flanking regions cor-
responding to the 5' and 3' flanking regions of AgGAS1A and 
AgGAS1B, respectively. Phusion® High-Fidelity DNA Polymerase 
(Finnzymes) was used and the PCR conditions were 98°C for 30 
sec, 30 cycles of 98°C for 10 sec, 50°C for 30 sec, 72°C for 1 
min and a final step of 72°C for 10 min. The amplified deletion 
modules were purified using the QIAquick PCR purification Kit 
(Qiagen) and used to transform A. gossypii ATCC 10895 mycelia 
(CMC) (1 g l−1) or tributyrin (10 ml l−1) were provided as carbon 
sources for mutants screening. Media were solidified with agar 
(20 g l−1) and when indicated 1 M sorbitol was added to AFM 
plates. Glucose (20 g l−1) was the carbon source used for liquid 
cultures.
Mutagenesis and selection. Mutations were induced in A. 
gossypii VTT D-10139836 with EMS. Several concentrations of 
EMS and different incubation periods were tested to determine 
a treatment suitable for 90–99% killing. Based on the results, 
mutagenesis was subsequently performed by diluting a spore sus-
pension of A. gossypii ten times in sodium phosphate buffer and 
incubating with 5% (v/v) EMS for 90 min at room temperature, 
with shaking. Mutagenized spores were diluted in 0.9% (w/v) 
NaCl and plated on agar-solidified AFM containing 0.1% (w/v) 
CMC plus 200 μg ml−1 G418 (Sigma) in order to keep the plas-
mid containing the recombinant EGI. A control was treated with 
water instead of EMS. Colonies appeared after 3 d.
For rapid screening of EGI production, mutants and the con-
trol strain of A. gossypii were incubated for 48 h on agar medium 
containing 0.1% (w/v) CMC as the sole carbon source and then 
flooded with 1% (w/v) Congo red solution according to the 
method of Teather and Wood.48 From this procedure, zones of 
CMC hydrolysis were clearly visible indicating cellulase pro-
duction and its activity on the substrate (CMC). Mutants were 
selected on the basis of clearing zone size after the Congo red 
treatment. Before flooding the plate with Congo red, colonies 
were transferred to agar-solidified AFM plus G418, with glucose 
as carbon source, in order to store the putative mutants. Selected 
mutants and A. gossypii VTT D-101398 were further assessed 
for cell growth and production of extracellular enzymes in AFM 
containing either CMC 0.1% (w/v), starch (10 g l−1) or trybutyrin 
(10 ml l−1).
Culture conditions. Spores were prepared by collecting 8−10 d 
old mycelia from agar-solidified medium, digesting with zymoly-
ase (75 mg ml−1) for 2 h and washing with a solution of 0.8% 
(w/v) NaCl, 20% (v/v) glycerol and 0.025% (v/v) Tween 20.
Submerged cultures were grown in 250 ml Erlenmeyer flasks 
containing 50 ml AFM with glucose and 200 μg ml−1 G418 
(Sigma) and incubated at 30°C, 200 rpm. Flasks were inoculated 
with spores which had been stored at −80°C. Dry cell weight was 
determined as previously described.36
Protein and enzymatic assays. Endoglucanase I (EGI). 
Endoglucanase I (EGI) activity was assayed as described previ-
ously36 by using 4-methylumbelliferyl-β-D-lactoside (MULac, 
Sigma) as substrate.
β-glucosidase activity was assayed according to the method 
described by Bailey and Nevalainen11 with 1 mM 4-nitrophenyl-
β-D-glucopyranoside (Sigma) as substrate.
α-amylase. The production of starch degrading enzymes on 
agar-solidified medium was detected by staining the surface with 
iodine solution49 to visualize zones in which starch had been 
broken down. Amylase activity by mutants exhibiting the larg-
est hydrolysis haloes were then tested in liquid cultures. Alpha-
amylase was measured by incubating 0.5 ml supernatant at 25°C 
for 3–4 min to achieve temperature equilibration, after which 
0.5 ml of 1% (w/v) starch solution (at 25°C) was added. After 3 
Figure 5. average eGI activity from supernatant of recombinant A. 
gossypii growing in flasks with aFM plus glucose at 30°c and 200 rpm. 
activities were measured with the MULac assay, described in materials 
and methods. Data represent average ± standard error of the mean 
obtained from three independent cultures. Aggas1AΔ mutant strain 
(NQ89) expressing eGI from the modified pMI519 plasmid (open circle), 
parent strain expressing eGI from the modified pMI519 plasmid (closed 
circle) and parent strain expressing eGI from the original pMI519 plas-
mid (closed triangle).
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AgGAS1B, was obtained by PCR from the plasmid pUGBLE3 
with the primers 352BleFW and 352BleRV (Table 1). The dele-
tion modules were used to transform A. gossypii NQ89 myce-
lia by electroporation as previously described.37 Transformants 
were selected on AFM agar containing 10 μg ml−1 phleomycin 
(InvivoGen).
Transformation of multinucleate mycelia leads to hetero-
karyotic mutants, which contain a mixture of transformed and 
parental nuclei. Clonal selection of homokaryotic mutants was 
achieved by isolating and growing single germinating spores.
Confirmation of GAS1-homolog genes deletion from the 
A. gossypii genome. Correct integration of the disruption cas-
sette on the AgGAS1A region was verified by analytical PCR with 
the primers V6FW_351 and V5RV_351, which anneal outside 
the deleted gene, and V4FW_351 and V5RV_351, which anneal 
inside the deleted region (Table 1, Figure 3A).
The single deletion of AgGAS1B was confirmed by PCR 
using following primers (Table 1, Figure 3E): V2FW_352 and 
V3RV_352, which anneal inside the deleted region; V2FW_352 
and Ver352_RV, annealing outside of the deleted region; and 
V2FW_352 and V1RV_NATPS, which anneal outside of 
the deleted region and in the middle of the NATPS module, 
respectively.
by electroporation, as previously described.37 Transformants were 
selected on AFM agar containing 100 μg ml−1 clonNAT 
(WERNER BioAgent).
The A. gossypii Aggas1AΔ homokaryotic strain was named A. 
gossypii NQ89. As this strain was resistant to clonNAT, the cas-
sette used for the deletion of the second AgGAS1 copy (AgGAS1B) 
conferred resistance to phleomycin (bler). Plasmid pUGGEN3 
was created by amplification of the GEN3 module from pGEN337 
with the primers GEN3_FW and GEN3_XhoI_RV (Table 1), 
which was digested with BglII and XhoI (New England BioLabs) 
and ligated to pUG6651 digested with the same enzymes. Using 
the primers ScTEFt_EcoRI_FW and ScTEFp_NcoI_RV (Table 
1), all of the pUGGEN3 sequence, with the exception of the 
kanr gene, was amplified with the Phusion® High-Fidelity DNA 
Polymerase (Finnzymes) as described above. The bler gene was 
obtained by PCR from plasmid pUG66 with the primers Ble_
FW and Ble_EcoRI_RV (Table 1). Both PCR fragments were 
digested with EcoRI and NcoI (New England BioLabs), and liga-
tion was performed with T4 DNA Ligase (Promega) according to 
the manufacturer instructions. The resulting plasmid was named 
pUGBLE3.
The deletion cassette BLE3 (resistance module for phleo-
mycin) used for the elimination of the second copy of AgGAS1, 
Table 1. Oligonucleotides used in this study 
Primer name Sequence
351FW 5' GTT caG TGG aca cGc aTT caa aca aTc GTG aGG TTT GcG GaG cTT TGa aTT TGG TTG aaa aTc GTa gtt acg gta ttt tac tat gg 
3'
351RV 5' GTa caT TTc TTT aaG cTa aaT GTG Tca aaG cTT GaG GcG aca aTa GaG TGc Tca aGa caT aGc TaT Gca aca gtg ttc ctt aat 
caa gg 3'
352FW 5' Taa GTT GGG Gcc TTG cGc aTa TTc GGa aGG Taa caG caG TcG cTa TaT TTG Tca aTc GcT aTG TTa TTc aaT aaG cTa Gcc 
ctg cag aac cgt tac ggt a 3'
352RV 5' aaa Gaa caT aGa GcT TcG ccT TaT aGa GTa aTa TaG aaG aGG cTG caT Gaa aaT cTa TTT TTa aaT Gaa GaT TaG ccc Gac 
ctg cag cca aac agt gtt 3'
GeN3_FW 5' GcT aGG GaT aac aGG GTa aT 3'
GeN3_XhoI_RV 5' ccG cTc GaG GaT cTG aTG aGG ccG TcT 3'
ScTeFt_ecoRI_FW 5' cGG aaT TcT cGa TGa GTT TTT cTa aGa G 3'
ScTeFp_NcoI_RV 5' TcT aTT cca TGG Taa TTa TaG TTc GTT Gac cG 3'
Ble_FW 5' Gca GGT cGa caa ccc TTa aT 3'
Ble_ecoRI_RV 5' cGG aaT TcT caT GaG aTG ccT Gca aG 3'
352BleFW 5' Taa GTT GGG Gcc TTG cGc aTa TTc GGa aGG Taa caG caG TcG cTa TaT TTG Tca aTc GcT aTG TTa TTc aaT aaG cTa Gcg 
cag gtc gac aac cct taa t 3'
352BleRV 5' aaa Gaa caT aGa GcT TcG ccT TaT aGa GTa aTa TaG aaG aGG cTG caT Gaa aaT cTa TTT TTa aaT Gaa GaT TaG ccc Gag 
cat agg cca cta gtg gat c 3'
V6FW_351 5' cTa GTG Gca TGT cTc GaG 3'
V4FW_351 5' Gca GGT GTG GTT Gac Gaa aTG caG 3'
V5RV_351 5' Gca GaT Gaa GTG cac aTc TTa cTG c 3‘
V2FW_352 5' caa cGa Tcc cGT cTG Tca TTG 3'
V3RV_352 5' GTa Gac GTT Gaa Gcc GTa Gaa GTc aG 3'
Ver352_RV 5' GcT GGa cTT TGG Tca TaG cc 3'
V1RV_NaTpS 5' GaT TcG TcG Tcc GaT TcG Tc 3'
Lower case letters indicate the sequences complementary to the template
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excised from pMI519 with BglII (NZYTech) and substituted with 
the GEN3 module obtained from pGEN337 digestion with the 
same enzyme. This plasmid is referred here as modified pMI519.
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Modified EGI expression plasmid construction. In order to 
evaluate the production of EGI by the Aggas1AΔ null mutant, 
one isolate, NQ89, was transformed with an EGI expression 
plasmid, or with the empty vector, pMI51636 as negative control. 
The expression plasmid pMI51936 containing EGI from T. reesei 
was modified by replacing the kanMX module, where kanr gene 
was flanked by the A. gossypii TEF1 promoter and S. cerevisiae 
ADH1 terminator, with the GEN3 module, in which the kanr 
gene is under the S. cerevisiae TEF2 promoter and terminator. The 
kanMX cassette together with the URA3 selection marker were 
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